. Author manuscript; available in PMC: 2020 Nov 18.

Published in final edited form as: Toxicol Appl Pharmacol. 2020 Sep 12;406:115242. doi: 10.1016/j.taap.2020.115242

Table 3.

Effect of inhalation of 30 mg/m³ FSD 8 on protein concentrations in the kidney.

Protein	Air 1 d	FSD 8 1 d	Air 7 d	FSD 8 7 d	Air 27 d	FSD 8 27 d
	μM/μg protein
Calbindin	6.03 ± 2.23	4.97 ± 0.80	7.62 ± 3.61	4.98 ± 0.79	N.D.	N.D.
Clusterin	10.51 ± 2.23	7.65 ± 2.61	11.03 ± 2.99	5.41 ± 2.36	N.D.	N.D.
GSTα	3.61 ± 1.03	3.83 ± 2.19	5.07 ± 1.91	2.50 ± 0.98	8.59 ± 3.75^*	1.28 ± 0.60
IP-10	4.23 ± 1.05	8.83 ± 2.75	9.88 ± 2.49^*	4.08 ± 1.02	10.97 ± 3.09	6.54 ± 0.63
KIM-1	10.54 ± 2.73	12.23 ± 5.11	13.18 ± 4.85	5.37 ± 1.19	14.01 ± 5.73	5.24 ± 1.64
OPN	6.48 ± 1.62	6.54 ± 1.39	11.34 ± 2.79^*	2.23 ± 0.59	9.05 ± 1.69	7.68 ± 1.68
TIMP-1	9.89 ± 5.36	13.96 ± 9.24	18.64 ± 9.22	7.77 ± 3.70	103.70 ± 35.83	101.42 ± 41.40
VEGF	7.66 ± 2.33	11.96 ± 3.93	11.86 ± 2.82^*	5.77 ± 1.58	16.63 ± 3.86	9.06 ± 1.81

FSD 8 vs. air-breathing controls,

P ≤ 0.05. N.D., not determined.